Artemisinin Antimalarial Drugs Market Regional Analysis:
Middle East and Africa Market Forecast
Middle East and Africa industry is anticipated to account for largest revenue share of 33.8% by 2035. The high prevalence of malaria and lack of hygiene in some parts of these regions particularly, in Africa is majorly fuelling the demand for advanced artemisinin antimalarial drugs.
Israel is one of the top markets for innovations in the medical device and pharma sectors, which is contributing to the development of advanced artemisinin antimalarial medications. The presence of advanced healthcare infrastructure and research organizations in the country is driving the sales of modern artemisinin antimalarial drugs. Israel has the world’s best and broadest health basket and according to the Government of Israel over 110 medical technologies and drugs were included in the basket at USD 178.5 million in 2024.
Nigeria is one of the African countries with a high burden of malaria, around 28% of the prevalence rate. International artemisinin antimalarial drug manufacturers are entering the Nigeria market to earn maximum revenue shares. The country is also carrying out several anti-malaria programs, which is fuelling the demand for injectable artemisinin antimalarial drugs.
Asia Pacific Market Statistics
Asia Pacific is foreseen to witness steady demand for artemisinin antimalarial drugs owing to the rise in malaria cases in some countries. China, Indonesia, and India are some of the economies with a high prevalence of malaria. The continuous innovations and malaria awareness programs are anticipated to boost the sales of artemisinin antimalarial drugs.
In India, the rising investments in healthcare infrastructure development and supportive government initiatives on malaria elimination are contributing to the market growth. For instance, the National Strategic Plan by India focuses on eliminating malaria by 2030.
